In B-cell hematological malignancies, the IRE1-XBP1 arm is essential due to the B-cell inherent secretory phenotype and GRP78 and/or XBP1 upregulation is associated with poorer outcome in leukaemia, lymphoma and multiple myeloma [81]. This evidence concerns the gene XBP1 and AL amyloidosis.